Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression
T. Zhou, J.-J. Fang, Y.-X. Zhou, Z.-P. Li, L. Jiang, W.-W. Han, Z.-H. Zhu Department of Emergency, Ningbo Medical Center Eastern Hospital, Ningbo, China.
The article “Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression, by T. Zhou, J.-J. Fang, Y.-X. Zhou, Z.-P. Li, L. Jiang, W.-W. Han, Z.-H. Zhu, published in Eur Rev Med Pharmacol Sci 2020; 24 (3): 1250-1257–DOI: 10.26355/eurrev_202002_20178–PMID: 32096155” has been withdrawn from the authors.
They stated that “during the last few months, new experimental data have been obtained and analyzed, so we want to rewrite the paper to further test the cell experiment and give more evidence to support our paper. It is difficult to repeat the part of the cell experiment, and the results need to be further improved. In addition, the internal reference pictures in the paper are wrong and need to be re experimented and modified. This needs more detailed studies and maybe a long time, so we want to withdraw our paper and resubmit it when it is ready”.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadLong non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
T. Zhou, J.-J. Fang, Y.-X. Zhou, Z.-P. Li, L. Jiang, W.-W. Han, Z.-H. Zhu
Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 20
Pages: 10308-10308
DOI: 10.26355/eurrev_202010_23365